Low-molecular-weight inhibitors of bacterial DNA-dependent RNA polymerase

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Molecular Biology

• Publication date

  2006-12-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1134/S0026893306060057PMID 17209424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutation in the Bacillus subtilis RNA Polymerase β′ Subunit Confers Resistance to Lipiarmycin

  2006cited by this paper
• Inhibition of bacterial RNA polymerase by streptolydigin: stabilization of a straight-bridge-helix active-center conformation.

  2005cited by this paper
• Structural basis of transcription inhibition by antibiotic streptolydigin.

  2005cited by this paper
• The involvement of the aspartate triad of the active center in all catalytic activities of multisubunit RNA polymerase

  2005cited by this paper
• Transcription regulation of the EcoRV restriction–modification system

  2005cited by this paper
• Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins.

  2005influential reference
• Structural basis for transcription inhibition by tagetitoxin

  2005cited by this paper
• Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase

  2005cited by this paper
• Mutation to rifampicin resistance at the beginning of the RNA polymerase β subunit gene in Escherichia coli

  2004cited by this paper
• Structural basis for transcription regulation by alarmone ppGpp.

  2004cited by this paper
• Erratum: Structural basis of transcription: Nucleotide selection by rotation in the RNA polymerase II active center (Cell (November 2004) 119 (481-489))

  2004influential reference
• Molecular mechanism of transcription inhibition by peptide antibiotic Microcin J25.

  2004cited by this paper
• A New Class of Bacterial RNA Polymerase Inhibitor Affects Nucleotide Addition

  2003cited by this paper
• Structure of microcin J25, a peptide inhibitor of bacterial RNA polymerase, is a lassoed tail.

  2003cited by this paper
• Unified two‐metal mechanism of RNA synthesis and degradation by RNA polymerase

  2003influential reference
• Promoting elongation with transcript cleavage stimulatory factors.

  2002influential reference
• Structural Basis of Transcription Initiation: An RNA Polymerase Holoenzyme-DNA Complex

  2002cited by this paper
• Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 Å resolution

  2002cited by this paper
• Mutations of Bacterial RNA Polymerase Leading to Resistance to Microcin J25*

  2002cited by this paper
• The β′ Subunit of Escherichia coli RNA Polymerase Is Not Required for Interaction with Initiating Nucleotide but Is Necessary for Interaction with Rifampicin*

  2001cited by this paper
• Structural Basis of Transcription: RNA Polymerase II at 2.8 Ångstrom Resolution

  2001cited by this paper
• Escherichia coli RNA Polymerase Is the Target of the Cyclopeptide Antibiotic Microcin J25

  2001cited by this paper
• Structural mechanism for rifampicin inhibition of bacterial rna polymerase.

  2001cited by this paper
• Differential effect of rpoB mutations on antibacterial activities of rifampicin and KRM-1648 against Staphylococcus aureus.

  2001cited by this paper
• RNA Polymerase Inhibitors with Activity against Rifampin-Resistant Mutants of Staphylococcus aureus

  2000cited by this paper
• Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 A resolution.

  1999cited by this paper
• Contribution of rpoB Mutations to Development of Rifamycin Cross-Resistance in Mycobacterium tuberculosis

  1998cited by this paper
• Biochemical analysis of catalytically crucial aspartate mutants of human immunodeficiency virus type 1 reverse transcriptase.

  1996cited by this paper
• A universally conserved region of the largest subunit participates in the active site of RNA polymerase III.

  1995cited by this paper
• Mechanistic aspects of tagetitoxin inhibition of RNA polymerase from Escherichia coli.

  1994cited by this paper
• RifR mutations in the beginning of the Escherichia coli rpoB gene

  1994cited by this paper
• Four contiguous amino acids define the target for streptolydigin resistance in the beta subunit of Escherichia coli RNA polymerase.

  1993cited by this paper
• Rifampicin region revisited. New rifampicin-resistant and streptolydigin-resistant mutants in the beta subunit of Escherichia coli RNA polymerase.

  1993cited by this paper
• Side chains involved in catalysis of the polymerase reaction of DNA polymerase I from Escherichia coli.

  1992cited by this paper
• Tagetitoxin inhibits RNA synthesis directed by RNA polymerases from chloroplasts and Escherichia coli.

  1990influential reference
• Resistance of Escherichia coli to rifampicin and sorangicin A--a comparison.

  1990cited by this paper
• Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.

  1988cited by this paper
• Inhibition of the RNA polymerase-catalyzed synthesis of RNA by marcellomycin. Preferential interference of the inhibitor with the stabilization of the ternary promoter-RNA polymerase-nascent RNA complex.

  1988cited by this paper
• Inhibition of the RNA polymerase-catalyzed synthesis of RNA by daunomycin. Effect of the inhibitor on the late steps of RNA chain initiation.

  1987cited by this paper
• The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria.

  1987cited by this paper
• Transcription of cloned eukaryotic ribosomal RNA genes.

  1986cited by this paper
• Mechanism and control of transcription initiation in prokaryotes.

  1985cited by this paper
• Initiation of transcription in vitro inhibited by lipiarmycin.

  1979influential reference
• On the mechanism of rifampicin inhibition of RNA synthesis.

  1978cited by this paper
• Lipiarmycin-resistant ribonucleic acid polymerase mutants of Bacillus subtilis

  1977cited by this paper
• Studies of the binding of Escherichia coli RNA polymerase to DNA. IV. The effect of rifampicin on binding and on RNA chain initiation.

  1972cited by this paper
• Escherichia coli RNA polymerase: purification, subunit structure, and factor requirements.

  1970cited by this paper
• Specific inhibition of nuclear RNA polymerase II by alpha-amanitin.

  1970cited by this paper
• Transcription of the tryptophan operon in Escherichia coli: rifampicin as an inhibitor of initiation.

  1970cited by this paper
• Specific Inhibition of Nuclear RNA Polymerase II by α-Amanitin

  1970cited by this paper
• Isolation and characterization of streptolydigin resistant RNA polymerase.

  1969cited by this paper
• Mode of Action of Streptolydigin

  1969cited by this paper
• Interaction of rifamycin with bacterial RNA polymerase.

  1968cited by this paper
• Action of daunomycin on nucleic acid metabolism in HeLa cells.

  1966cited by this paper

• Mechanisms of antibiotics inhibiting bacterial RNA polymerase.

  2019cites this paper
• Determination of multidrug resistance mechanisms in Clostridium perfringens type A isolates using RNA sequencing and 2D-electrophoresis

  2018cites this paper
• Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.

  2011cites this paper
• Synthesis of de novo designed small-molecule inhibitors of bacterial RNA polymerase

  2008cites this paper
• Soma Mandal Graduate Assistant

  year unknowncites this paper